Biological preparations for intravitreal injection to slow down loss of eye sight due to wet age macular degeneration (wet AMD), diabetic macular edema (DME) and retinal vein occlusion (RVO) and other related eye diseases; biological preparations for use in intravitreal therapy; pharmaceutical preparations for the treatment of wet AMD, DME, RVO and other related eye diseases; anti-VEGF intravitreal injections, pharmaceutical preparations for slowing down blindness due to proliferation of blood vessels in the eye.
FORMALIZED
on 28 Feb 2024
RANLUSPEC
LUPIN INC.
2312612 · 28 Feb 2024
005
Class 005
Pharmaceutical Products
Biological preparations for intravitreal injection to slow down loss of eye sight due to wet age macular degeneration (wet AMD), diabetic macular edema (DME) and retinal vein occlusion (RVO) and other related eye diseases; biological preparations for use in intravitreal therapy; pharmaceutical preparations for the treatment of wet AMD, DME, RVO and other related eye diseases; anti-VEGF intravitreal injections, pharmaceutical preparations for slowing down blindness due to proliferation of blood vessels in the eye.
Biological preparations for intravitreal injection to slow down loss o...
